Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myovascular Niche: The Role of Endothelial Cells in Skeletal Muscle Health and Disease.

Circulation research·2026
Same author

Elevated mitochondrial Ca<sup>2+</sup> impairs satellite cell pool expansion in response to skeletal muscle injury.

Stem cell reports·2026
Same author

Lipid nanoparticle delivery of antisense gapmers attenuates pathology in a mouse model of facioscapulohumeral muscular dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Progress on cell therapy for skeletal muscle disorders.

Advanced drug delivery reviews·2026
Same author

Necessity of Notch3 signaling in myofiber maturation in a pluripotent stem cell transplant model.

Skeletal muscle·2026
Same author

Corrigendum to 'Small-scale siRNA screen reveals WWC2 as a novel regulator of cardiomyocyte mitosis' [Journal of Molecular and Cellular Cardiology 210 (2025) 127-136].

Journal of molecular and cellular cardiology·2025

Related Experiment Video

Updated: Jun 3, 2026

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

Functional myogenic engraftment from mouse iPS cells.

Radbod Darabi1, Weihong Pan, Darko Bosnakovski

  • 1Lillehei Heart Institute, Department of Medicine, University of Minnesota, 4-124 Nils Hasselmo Hall, 312 Church St. S.E., Minneapolis, 55455 MN, USA.

Stem Cell Reviews and Reports
|April 5, 2011
PubMed
Summary
This summary is machine-generated.

Induced pluripotent stem (iPS) cells can effectively treat muscle disorders. Transplanting iPS-derived myogenic progenitors into dystrophic mice improved muscle function, showing therapeutic potential for muscular dystrophies.

More Related Videos

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
05:35

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Published on: May 31, 2022

Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4
13:02

Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4

Published on: April 7, 2008

Related Experiment Videos

Last Updated: Jun 3, 2026

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
05:35

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Published on: May 31, 2022

Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4
13:02

Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4

Published on: April 7, 2008

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Muscle biology

Background:

  • Direct reprogramming generates patient-specific induced pluripotent stem (iPS) cells.
  • Therapeutic applications of iPS cells for functional tissue repair remain limited.
  • Muscular dystrophies represent a significant unmet medical need.

Purpose of the Study:

  • To demonstrate the therapeutic potential of iPS cells for treating muscle disorders.
  • To establish a robust method for generating myogenic progenitors from iPS cells.
  • To evaluate the efficacy of iPS-derived myogenic progenitors in a mouse model of muscular dystrophy.

Main Methods:

  • Generation of iPS cells from adult fibroblasts.
  • Conditional expression of Pax7 to derive myogenic progenitors.
  • Transplantation of iPS-derived myogenic progenitors into dystrophic mouse models.

Main Results:

  • Successful generation of Pax7-expressing iPS-derived myogenic progenitors.
  • Extensive engraftment of transplanted cells in dystrophic muscles.
  • Significant improvement in muscle contractility following transplantation.

Conclusions:

  • iPS cells possess myogenic regenerative potential.
  • iPS-derived myogenic progenitors show promise for treating muscle disorders.
  • This study provides a rationale for the therapeutic use of iPS cells in muscular dystrophies.